A Medication Is Being Recalled In Canada Due To Bacterial Contamination & Risk Of Infection
"Do not use the affected product."
A Government of Canada sign.
Health Canada has published a health product recall and public advisory over two lots of medication.
On February 19, the agency advised that the affected medication may contain the presence of bacterial contamination and possible risk of infection.
"Do not use the affected product," advises both the recall and advisory.
Information on the affected item:
- APO-Mometasone nasal spray, 50 mcg/metered spray
- Drug Identification Number: 02403587
- Lot numbers: TX5343, TZ2586
"Apotex Inc. is recalling two lots of APO-Mometasone nasal spray due to possible bacterial contamination with Burkholderia cepacia complex (Bcc)," says the recall. "Bcc is a group of bacteria that poses a low medical risk to most healthy people; however, children, those with chronic lung diseases, people who are pregnant, seniors and those with a weakened immune system may be at a higher risk of illness."
The symptoms of Bcc range from nothing to serious infections that may result in sepsis and death, and the bacteria is often resistant to antibiotics.
"People experiencing persistent or worsening symptoms, such as fevers, or facial pain or pressure, should seek medical attention," says the recall.
As well, supply of the medication may be be compromised due to the recall, so the people are advised to contact their healthcare providers for alternative treatments.
This article's cover image was used for illustrative purposes only.